Developing a CBCT-Guided Online Adaptive Radiotherapy Approach for Isotoxic Delivery of Ultra-High Dose to Oligometastatic Disease in Combination with Immunotherapy

被引:0
|
作者
Musunuru, H. B. [1 ]
Lynch, C. [2 ]
Katipally, R. R. [2 ]
Nasser, N. [3 ]
Olson, A. C. [1 ]
Chmura, S. J. [2 ]
Gan, G. N. [4 ]
Luke, J. J. [5 ,6 ]
Redler, G. [3 ]
机构
[1] UPMC Hillman Canc Ctr, Dept Radiat Oncol, Pittsburgh, PA USA
[2] Univ Chicago, Med Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[4] Univ Kansas, Med Ctr, Dept Radiat Oncol, Kansas City, KS 66103 USA
[5] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Pittsburgh, PA USA
[6] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3336
引用
收藏
页码:E594 / E594
页数:1
相关论文
共 3 条
  • [1] Introducing An Isotoxic Paradigm for Delivery of Ultra-High Doses to Oligometastatic Disease Using Ethos Online Adaptive Radiotherapy
    Redler, G.
    Musunuru, H.
    Katipally, R.
    Lynch, C.
    Nasser, N.
    Olson, A.
    Gan, G.
    Luke, J.
    Chmura, S.
    MEDICAL PHYSICS, 2022, 49 (06) : E381 - E382
  • [2] Developing training for RTT-led CBCT-guided daily online adaptive radiotherapy for urological cancer
    Graham, S.
    Daly, K.
    Ward, A.
    Martinou, M.
    Withers, D.
    Kidane, G.
    Almond, E.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S601 - S602
  • [3] Can Rational Combination of Ultra-high Dose Rate FLASH Radiotherapy with Immunotherapy Provide a Novel Approach to Cancer Treatment?
    Zhang, Y.
    Ding, Z.
    Perentesis, J. P.
    Khuntia, D.
    Pfister, S. X.
    Sharma, R. A.
    CLINICAL ONCOLOGY, 2021, 33 (11) : 713 - 722